{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:45:23Z","timestamp":1792233923161,"version":"4.4.0"},"reference-count":160,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.tins.2023.06.003","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T21:50:04Z","timestamp":1689457804000},"page":"750-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["More than just risk for Alzheimer\u2019s disease: APOE \u03b54's impact\u00a0on the aging brain"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-6629","authenticated-orcid":false,"given":"Justin M.","family":"Palmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Huentelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2023.06.003_bb0005","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"Farrer","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2023.06.003_bb0010","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/mp.2011.52","article-title":"APOE and Alzheimer disease: a major gene with semi-dominant inheritance","volume":"16","author":"Genin","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-020-00740-0","article-title":"The association of APOE \u03b54 with cognitive function over the adult life course and incidence of dementia: 20years follow-up of the Whitehall II study","volume":"13","author":"Gharbi-Meliani","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0020","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1177\/00048674221079217","article-title":"Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: age- and sex-stratified cohort study","volume":"56","author":"Liew","year":"2022","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0025","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1212\/WNL.0000000000013017","article-title":"Predictors of incident mild cognitive impairment and its course in a diverse community-based population","volume":"98","author":"Angevaare","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0030","first-page":"1","article-title":"Walking pace, handgrip strength, age, APOE genotypes, and new-onset dementia: the UK Biobank prospective cohort study","volume":"15","author":"He","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0035","doi-asserted-by":"crossref","first-page":"E1033","DOI":"10.1503\/cmaj.180066","article-title":"Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study","volume":"190","author":"Rasmussen","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.tins.2023.06.003_bb0040","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.06.003_bb0045","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/alz.12287","article-title":"Increased APOE \u03b54 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds","volume":"17","author":"Griswold","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0050","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41380-022-01729-x","article-title":"Global and local ancestry modulate APOE association with Alzheimer\u2019s neuropathology and cognitive outcomes in an admixed sample","volume":"27","author":"Naslavsky","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0055","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JAD-201606","article-title":"The proportion of APOE4 carriers among non-demented individuals: a pooled analysis of 389,000 community-dwellers","volume":"81","author":"Wang","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0060","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","article-title":"APOE \u03b54 is associated with severity of Lewy body pathology independent of Alzheimer pathology","volume":"91","author":"Dickson","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0065","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-022-02421-8","article-title":"APOE4 exacerbates \u03b1-synuclein seeding activity and contributes to neurotoxicity in Alzheimer\u2019s disease with Lewy body pathology","volume":"143","author":"Jin","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.06.003_bb0075","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.06.003_bb0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","article-title":"Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE \u03b54 haplotype status: a community-based cohort study","volume":"17","author":"Yang","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","article-title":"Association of apolipoprotein E \u03b54 with transactive response DNA-binding protein 43","volume":"75","author":"Wennberg","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0090","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/alz.12885","article-title":"AD and non-AD mediators of the pathway between the APOE genotype and cognition","volume":"19","author":"Nichols","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0095","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/nan.12529","article-title":"Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer\u2019s disease","volume":"45","author":"Tzioras","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.tins.2023.06.003_bb0100","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0105","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.06.003_bb0110","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/glia.23974","article-title":"Expression and secretion of apoE isoforms in astrocytes and microglia during inflammation","volume":"69","author":"Lanfranco","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.tins.2023.06.003_bb0115","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.tins.2023.06.003_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.tins.2023.06.003_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41467-019-14279-8","article-title":"Exceptionally low likelihood of Alzheimer\u2019s dementia in APOE2 homozygotes from a 5,000-person neuropathological study","volume":"11","author":"Reiman","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.06.003_bb0135","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/alz.12487","article-title":"The protective gene dose effect of the APOE \u03b52 allele on gray matter volume in cognitively unimpaired individuals","volume":"18","author":"Salvad\u00f3","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0140","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/jgs.15727","article-title":"Apolipoprotein E genotypes, age, race, and cognitive decline in a population sample","volume":"67","author":"Rajan","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.tins.2023.06.003_bb0145","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1037\/neu0000501","article-title":"Effects of APOE on cognitive aging in community-dwelling older adults","volume":"33","author":"Reas","year":"2019","journal-title":"Neuropsychology"},{"key":"10.1016\/j.tins.2023.06.003_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0350-4","article-title":"APOE2: protective mechanism and therapeutic implications for Alzheimer\u2019s disease","volume":"15","author":"Li","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.06.003_bb0155","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10571-016-0334-7","article-title":"The science of vascular contributions to cognitive impairment and dementia (VCID): a framework for advancing research priorities in the cerebrovascular biology of cognitive decline","volume":"36","author":"Corriveau","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.tins.2023.06.003_bb0160","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fnagi.2019.00128","article-title":"Precision aging: applying precision medicine to the field of cognitive aging","volume":"11","author":"Ryan","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0165","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/jamaneurol.2022.3543","article-title":"Estimating the prevalence of dementia and mild cognitive impairment in the US: the 2016 health and retirement study harmonized cognitive assessment protocol project","volume":"79","author":"Manly","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cortex.2018.03.025","article-title":"APOE genotype and cognition in healthy individuals at risk of Alzheimer\u2019s disease: a review","volume":"104","author":"O\u2019Donoghue","year":"2018","journal-title":"Cortex"},{"key":"10.1016\/j.tins.2023.06.003_bb0175","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1212\/WNL.54.7.1492","article-title":"APOE-epsilon4 is associated with memory decline in cognitively impaired elderly","volume":"54","author":"Dik","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0180","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1212\/01.WNL.0000129533.26544.BF","article-title":"Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele","volume":"62","author":"Caselli","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0185","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/archneur.64.9.1306","article-title":"Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment","volume":"64","author":"Caselli","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMoa0809437","article-title":"Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect","volume":"361","author":"Caselli","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0195","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1212\/WNL.0b013e3182167147","article-title":"Longitudinal modeling of frontal cognition in APOE \u03b54 homozygotes, heterozygotes, and noncarriers","volume":"76","author":"Caselli","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0200","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1212\/01.WNL.0000055875.26908.24","article-title":"The role of APOE-\u03b54 in longitudinal cognitive decline: MacArthur Studies of Successful Aging","volume":"60","author":"Bretsky","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0205","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0197-4580(03)00006-X","article-title":"Apolipoprotein E \u03b54 affects new learning in cognitively normal individuals at risk for Alzheimer\u2019s disease","volume":"24","author":"Baxter","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0210","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1037\/a0031642","article-title":"APOE \u03b54, Alzheimer\u2019s disease pathology, cerebrovascular disease, and cognitive change over the years prior to death","volume":"28","author":"Yu","year":"2013","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0215","doi-asserted-by":"crossref","first-page":"e2414","DOI":"10.1212\/WNL.0000000000011883","article-title":"Association of APOE genotype with heterogeneity of cognitive decline rate in Alzheimer disease","volume":"96","author":"Qian","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0220","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200055","article-title":"Neuropathology-independent association between APOE genotype and cognitive decline rate in the normal aging-early Alzheimer continuum","volume":"9","author":"Qian","year":"2023","journal-title":"Neurol Genet."},{"key":"10.1016\/j.tins.2023.06.003_bb0225","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jagp.2013.01.035","article-title":"Apolipoprotein E \u03b54 and later-life decline in cognitive function and grip strength","volume":"21","author":"Batterham","year":"2013","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0230","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/gerona\/glt103","article-title":"APOE genotype and cognitive change in young, middle-aged, and older adults living in the community","volume":"69","author":"Bunce","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.tins.2023.06.003_bb0235","article-title":"The apolipoprotein E antagonistic pleiotropy hypothesis: review and recommendations","volume":"2011","author":"Tuminello","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0240","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.08.009","article-title":"Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans","volume":"94","author":"Weissberger","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.tins.2023.06.003_bb0245","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43587-021-00117-4","article-title":"Dissociable effects of APOE-\u03b54 and \u03b2-amyloid pathology on visual working memory","volume":"1","author":"Lu","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0250","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.neurobiolaging.2014.01.145","article-title":"Cognitive and neural signatures of the APOE E4 allele in mid-aged adults","volume":"35","author":"Evans","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0255","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1017\/S1355617718000577","article-title":"Evidence for reduced autobiographical memory episodic specificity in cognitively normal middle-aged and older individuals at increased risk for Alzheimer\u2019s disease dementia","volume":"24","author":"Grilli","year":"2018","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.tins.2023.06.003_bb0260","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1017\/S1355617720001319","article-title":"Autobiographical memory fluency reductions in cognitively unimpaired middle-aged and older adults at increased risk for Alzheimer\u2019s disease dementia","volume":"27","author":"Grilli","year":"2021","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.tins.2023.06.003_bb0265","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neurobiolaging.2018.09.017","article-title":"Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories","volume":"13","author":"Zokaei","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0270","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1017\/S1355617722000455","article-title":"The impact of context on pattern separation for objects among younger and older apolipoprotein \u03b54 carriers and noncarriers","volume":"29","author":"Palmer","year":"2022","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.tins.2023.06.003_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neurobiolaging.2016.12.022","article-title":"Executive function performance and change in aging is predicted by apolipoprotein E, intensified by catechol-O-methyltransferase and brain-derived neurotrophic factor, and moderated by age and lifestyle","volume":"52","author":"Sapkota","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0280","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1037\/neu0000147","article-title":"Association of the apolipoprotein E genotype with memory performance and executive functioning in cognitively intact elderly","volume":"29","author":"Luck","year":"2015","journal-title":"Neuropsychology"},{"key":"10.1016\/j.tins.2023.06.003_bb0285","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1037\/0882-7974.14.2.295","article-title":"Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer\u2019s disease","volume":"14","author":"Bondi","year":"1999","journal-title":"Psychol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0290","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41380-022-01900-4","article-title":"Predictors of longitudinal cognitive ageing from age 70 to 82 including APOE e4 status, early-life and lifestyle factors","volume":"28","author":"Corley","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0295","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210542","article-title":"Activated microglia mitigate A\u03b2-associated tau seeding and spreading","volume":"218","author":"Gratuze","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0305","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1038\/s41467-021-23762-0","article-title":"Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease","volume":"12","author":"Fitz","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.06.003_bb0310","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/jnen\/nlab085","article-title":"Inflammatory pathways are impaired in Alzheimer disease and differentially associated with apolipoprotein E status","volume":"80","author":"Kloske","year":"2021","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0315","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.stem.2022.07.005","article-title":"Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity","volume":"29","author":"Victor","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tins.2023.06.003_bb0320","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.06.003_bb0325","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1101\/lm.030031.112","article-title":"Young APOE4 targeted replacement mice exhibit poor spatial learning and memory, with reduced dendritic spine density in the medial entorhinal cortex","volume":"20","author":"Rodriguez","year":"2013","journal-title":"Learn. Mem."},{"key":"10.1016\/j.tins.2023.06.003_bb0330","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jnc.15665","article-title":"Independent APOE4 knock-in mouse models display reduced brain APOE protein, altered neuroinflammation, and simplification of dendritic spines","volume":"163","author":"Sepulveda","year":"2022","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.06.003_bb0335","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neurobiolaging.2018.09.003","article-title":"Dendritic spine remodeling accompanies Alzheimer\u2019s disease pathology and genetic susceptibility in cognitively normal aging","volume":"73","author":"Boros","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0340","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/cns.12720","article-title":"Hippocampal synaptic and neural network deficits in young mice carrying the human APOE4 gene","volume":"23","author":"Sun","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0345","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamaneurol.2013.4544","article-title":"Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study","volume":"71","author":"Dean","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117243","article-title":"Longitudinal white matter and cognitive development in pediatric carriers of the apolipoprotein \u03b54 allele","volume":"222","author":"Remer","year":"2020","journal-title":"NeuroImage"},{"key":"10.1016\/j.tins.2023.06.003_bb0355","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/hmg\/ddx155","article-title":"APOE \u03b54\/\u03b54 diminishes neurotrophic function of human iPSC-derived astrocytes","volume":"26","author":"Zhao","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2023.06.003_bb0360","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jnc.15781","article-title":"Apolipoprotein E \u03b54 modulates astrocyte neuronal support functions in the presence of amyloid-\u03b2","volume":"165","author":"Fleeman","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tins.2023.06.003_bb0365","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41398-020-01137-1","article-title":"Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer\u2019s disease","volume":"11","author":"Chatterjee","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcac135","article-title":"Astrocytic function is associated with both amyloid-\u03b2 and tau pathology in non-demented APOE \u03b54 carriers","volume":"4","author":"Spotorno","year":"2022","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2023.06.003_bb0375","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1038\/s41467-018-06301-2","article-title":"Apo\u03b54 disrupts neurovascular regulation and undermines white matter integrity and cognitive function","volume":"9","author":"Koizumi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2023.06.003_bb0380","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0385","article-title":"A \u201cmulti-omics\u201d analysis of blood-brain barrier and synaptic dysfunction in APOE4 mice","volume":"219","author":"Barisano","year":"2022","journal-title":"JEM"},{"key":"10.1016\/j.tins.2023.06.003_bb0390","doi-asserted-by":"crossref","first-page":"18636","DOI":"10.1038\/s41598-021-98061-1","article-title":"Effects of apolipoprotein E isoform, sex, and diet on insulin BBB pharmacokinetics in mice","volume":"11","author":"Rhea","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2023.06.003_bb0395","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114408","article-title":"Blood-based biomarkers for Alzheimer\u2019s disease","volume":"14","author":"Leuzy","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0400","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neurobiolaging.2014.12.008","article-title":"APOE \u03b54 moderates amyloid-related memory decline in preclinical Alzheimer\u2019s Disease","volume":"36","author":"Lim","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0405","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1007\/s11682-019-00069-9","article-title":"Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity","volume":"14","author":"Lyall","year":"2020","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.tins.2023.06.003_bb0410","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3233\/JAD-215556","article-title":"APOE4 and confluent white matter hyperintensities have a synergistic effect on episodic memory impairment in prodromal dementia","volume":"87","author":"Kumar","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neurobiolaging.2017.01.014","article-title":"APOE \u03b54 status is associated with white matter hyperintensities volume accumulation rate independent of AD diagnosis","volume":"53","author":"Sudre","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1457","article-title":"White matter hypointensities and hyperintensities have equivalent correlations with age and CSF \u03b2-amyloid in the nondemented elderly","volume":"9","author":"Wei","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.tins.2023.06.003_bb0425","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2017.02.014","article-title":"Interaction of APOE e4 and poor glycemic control predicts white matter hyperintensity growth from 73 to 76","volume":"54","author":"Cox","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0430","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0435","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0440","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2023.06.003_bb0445","doi-asserted-by":"crossref","first-page":"6820","DOI":"10.1073\/pnas.0900345106","article-title":"Fibrillar amyloid-\u03b2 burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease","volume":"106","author":"Reiman","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2023.06.003_bb0450","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/WNL.0000000000003234","article-title":"Relative effect of APOE epsilon4 on neuroimaging biomarker changes across the lifespan","volume":"87","author":"Gonneaud","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0455","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/WNL.0b013e31824365ab","article-title":"APOE modifies the association between Abeta load and cognition in cognitively normal older adults","volume":"78","author":"Kantarci","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0460","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.biopsych.2004.07.021","article-title":"Cerebrospinal fluid beta-amyloid 1-42 and tau in control subjects at risk for Alzheimer\u2019s disease: the effect of APOE epsilon4 allele","volume":"56","author":"Sunderland","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0465","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.21843","article-title":"APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging","volume":"67","author":"Morris","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0470","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","article-title":"Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-amyloid across the adult life span","volume":"72","author":"Jack","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0475","article-title":"Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: an age-continuous perspective","author":"Zhang","year":"2022","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0480","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.0000000000005303","article-title":"Resistance vs resilience to Alzheimer disease: clarifying terminology for preclinical studies","volume":"90","author":"Arenaza-Urquijo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13195-019-0479-y","article-title":"Concepts for brain aging: resistance, resilience, reserve, and compensation","volume":"11","author":"Montine","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0490","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.tins.2023.06.003_bb0495","first-page":"2740","article-title":"Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease","volume":"141","author":"Dani","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.tins.2023.06.003_bb0500","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/bpa.12763","article-title":"Characterization of the 18 kDa translocator protein (TSPO) expression in post-mortem normal and Alzheimer\u2019s disease brains","volume":"30","author":"Gui","year":"2020","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2023.06.003_bb0505","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fnagi.2018.00114","article-title":"Deciphering the astrocyte reaction in Alzheimer\u2019s disease","volume":"10","author":"Perez-Nievas","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0510","doi-asserted-by":"crossref","first-page":"e2944","DOI":"10.1212\/WNL.0000000000012109","article-title":"Astrocyte biomarkers in Alzheimer disease: a systematic review and meta-analysis","volume":"96","author":"Bellaver","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0515","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.0b013e31822313dc","article-title":"Diffusion tensor imaging and cognitive function in older adults with no dementia","volume":"77","author":"Kantarci","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0520","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.neuropsychologia.2012.03.033","article-title":"Age-related changes in parahippocampal white matter integrity: a diffusion tensor imaging study","volume":"50","author":"Rogalski","year":"2012","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.tins.2023.06.003_bb0525","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuroscience.2017.05.048","article-title":"Disrupted white matter structural networks in healthy older adult APOE \u03b54 carriers - an international multicenter DTI study","volume":"357","author":"Cavedo","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2023.06.003_bb0530","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1212\/01.wnl.0000204180.25361.48","article-title":"Altered brain white matter integrity in healthy carriers of the APOE \u03b54 allele: a risk for AD?","volume":"66","author":"Persson","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0535","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.neuroimage.2010.08.052","article-title":"Age-related differences in white matter integrity and cognitive function are related to APOE status","volume":"54","author":"Ryan","year":"2011","journal-title":"NeuroImage"},{"key":"10.1016\/j.tins.2023.06.003_bb0540","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.neurobiolaging.2008.08.006","article-title":"White matter diffusion alterations in normal women at risk of Alzheimer\u2019s disease","volume":"31","author":"Smith","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073107","article-title":"Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition","volume":"8","author":"Arfanakis","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2023.06.003_bb0550","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bbi.2017.04.022","article-title":"Circulating inflammatory biomarkers in relation to brain structural measurements in a non-demented elderly population","volume":"65","author":"Gu","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.tins.2023.06.003_bb0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2023.06.003_bb0560","doi-asserted-by":"crossref","first-page":"15886","DOI":"10.1038\/s41598-020-72878-8","article-title":"Cerebrospinal fluid sTREM2 in Alzheimer\u2019s disease: comparisons between clinical presentation and AT classification","volume":"10","author":"Knapskog","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2023.06.003_bb0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.06.003_bb0570","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3389\/fneur.2020.00448","article-title":"Acute neurofilament light chain plasma levels correlate with stroke severity and clinical outcome in ischemic stroke patients","volume":"11","author":"Nielsen","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0575","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1089\/neu.2019.6375","article-title":"A serum protein biomarker panel improves outcome prediction in human traumatic brain injury","volume":"20","author":"Thelin","year":"2019","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.tins.2023.06.003_bb0580","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00702-021-02411-2","article-title":"Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration","volume":"129","author":"de San","year":"2022","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.tins.2023.06.003_bb0585","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13195-015-0161-y","article-title":"Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer\u2019s disease","volume":"7","author":"Hellwig","year":"2015","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0590","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00401-018-1851-x","article-title":"Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology","volume":"136","author":"Portelius","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2023.06.003_bb0595","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1212\/WNL.0000000000002423","article-title":"Increased CSF neurogranin concentration is specific to Alzheimer disease","volume":"86","author":"Wellington","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.tins.2023.06.003_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2020.584743","article-title":"Neurogranin: a potential biomarker of neurological and mental diseases","volume":"12","author":"Xiang","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0605","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.2967\/jnumed.121.263201","article-title":"Imaging of synaptic density in neurodegenerative disorders","volume":"63","author":"Carson","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0610","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neurobiolaging.2019.05.020","article-title":"Sex differences in brain aging and predictors of neurodegeneration in cognitively healthy older adults","volume":"81","author":"Armstrong","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101904","article-title":"Hippocampal volume across age: nomograms derived from over 19,700 people in UK Biobank","volume":"23","author":"Nobis","year":"2019","journal-title":"NeuroImage Clin."},{"key":"10.1016\/j.tins.2023.06.003_bb0620","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2020.01.011","article-title":"Differential annualized rates of hippocampal subfields atrophy in aging and future Alzheimer\u2019s clinical syndrome","volume":"90","author":"Nadal","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0625","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3389\/fnagi.2018.00320","article-title":"The volume of hippocampal subfields in relation to decline of memory recall across the adult lifespan","volume":"10","author":"Zheng","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0630","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pscychresns.2012.06.002","article-title":"Hippocampal and entorhinal cortex volume decline in cognitively intact elderly","volume":"211","author":"Thomann","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.tins.2023.06.003_bb0635","doi-asserted-by":"crossref","first-page":"8237","DOI":"10.1523\/JNEUROSCI.5506-12.2013","article-title":"Brain changes in older adults at very low risk for Alzheimer\u2019s disease","volume":"33","author":"Fjell","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0640","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jalz.2018.01.016","article-title":"Effects of APOE-\u03b54 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer\u2019s disease","volume":"14","author":"Cacciaglia","year":"2018","journal-title":"Alzheimer\u2019s Dement: J. Alzheimers Assoc."},{"key":"10.1016\/j.tins.2023.06.003_bb0645","article-title":"The human hippocampus and its subfield volumes across age, sex and APOE e4 status","volume":"3","author":"Veldsman","year":"2020","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2023.06.003_bb0650","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2014-307719","article-title":"APOE genotype and neuroimaging markers of Alzheimer\u2019s disease: systematic review and meta-analysis","volume":"86","author":"Liu","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0655","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2018.10.024","article-title":"Predictors of neurodegeneration differ between cognitively normal and subsequently impaired older adults","volume":"75","author":"Armstrong","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101818","article-title":"APOE-\u03b54 risk variant for Alzheimer\u2019s disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals","volume":"23","author":"Cacciaglia","year":"2019","journal-title":"Neuroimage Clin."},{"key":"10.1016\/j.tins.2023.06.003_bb0665","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.neuron.2007.10.038","article-title":"Disruption of large-scale brain systems in advanced aging","volume":"56","author":"Andrews-Hanna","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2023.06.003_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropsychologia.2021.108138","article-title":"Individual differences in the relationship between episodic detail generation and resting state functional connectivity vary with age","volume":"166","author":"Matijevic","year":"2022","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.tins.2023.06.003_bb0675","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","article-title":"Amyloid plaques disrupt resting state default mode network connectivity in cognitively normal elderly","volume":"67","author":"Sheline","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0680","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of functional connectivity in clinically normal older adults harboring amyloid burden","volume":"29","author":"Hedden","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0685","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fnagi.2016.00151","article-title":"Higher brain perfusion may not support memory functions in cognitively normal carriers of the ApoE \u03b54 allele compared to non-carriers","volume":"8","author":"Zlatar","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2023.06.003_bb0690","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13195-016-0231-9","article-title":"Peripheral apoE isoform levels in cognitively normal APOE \u03b53\/\u03b54 individuals are associated with regional gray matter volume and cerebral glucose metabolism","volume":"9","author":"Nielsen","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0695","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/RLI.0000000000000723","article-title":"A comprehensive view on MRI techniques for imaging blood-brain barrier integrity","volume":"56","author":"Elschot","year":"2021","journal-title":"Investig. Radiol."},{"key":"10.1016\/j.tins.2023.06.003_bb0700","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.2806","article-title":"Evidence of emerging BBB changes in mid-age apolipoprotein E epsilon-4 carriers","volume":"12","author":"Alruwais","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.tins.2023.06.003_bb0705","doi-asserted-by":"crossref","DOI":"10.1002\/alz.12974","article-title":"Placental growth factor as a sensitive biomarker for vascular cognitive impairment","author":"Hinman","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2023.06.003_bb0710","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3233\/JAD-215053","article-title":"Plasma EFEMP1 is associated with brain aging and dementia: the Framingham Heart Study","volume":"85","author":"McGrath","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0715","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/cercor\/bhl103","article-title":"Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers","volume":"17","author":"Mondadori","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.tins.2023.06.003_bb0720","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/jnnp.2006.108183","article-title":"APOE and recovery from TBI in a U.S. military population: evidence for a compensatory mechanism?","volume":"78","author":"Han","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tins.2023.06.003_bb0725","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neurobiolaging.2008.05.021","article-title":"APOE genotype is associated with left-handedness and visuospatial skills in children","volume":"31","author":"Bloss","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0730","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3940(00)01569-X","article-title":"Intelligence and event-related potentials for young female human volunteer apolipoprotein E epsilon4 and non-epsilon4 carriers","volume":"294","author":"Yu","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.tins.2023.06.003_bb0735","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2307\/2406060","article-title":"Pleiotropy, natural selection, and the evolution of senescence","volume":"11","author":"Williams","year":"1957","journal-title":"Evolution"},{"key":"10.1016\/j.tins.2023.06.003_bb0740","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.neurobiolaging.2019.04.011","article-title":"APOE effects on cognition from childhood to adolescence","volume":"84","author":"Reynolds","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.tins.2023.06.003_bb0745","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1017\/S1355617720001034","article-title":"Apolipoprotein E (APOE) \u03b54 status moderates the relationship between close-range blast exposure and cognitive functioning","volume":"27","author":"Wooten","year":"2021","journal-title":"J. Int. Neuropsychol."},{"key":"10.1016\/j.tins.2023.06.003_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.735206","article-title":"APOE-\u03b54 is associated with reduced verbal memory performance and higher emotional, cognitive, and everyday executive function symptoms two months after mild traumatic brain injury","volume":"13","author":"Hellstr\u00f8m","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0755","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1001\/archneur.62.12.1881","article-title":"Identification of Alzheimer\u2019s disease risk by functional magnetic resonance imaging","volume":"62","author":"Fleisher","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tins.2023.06.003_bb0760","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/0894-4105.21.1.1","article-title":"APOE genotype and cognitive functioning in a large age-stratified population sample","volume":"21","author":"Jorm","year":"2007","journal-title":"Neuropsychology"},{"key":"10.1016\/j.tins.2023.06.003_bb0765","doi-asserted-by":"crossref","first-page":"19849","DOI":"10.1038\/s41598-021-98117-2","article-title":"Associations between race, APOE genotype, cognition, and mortality among urban middle-aged white and African American adults","volume":"11","author":"Weiss","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2023.06.003_bb0770","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13195-021-00855-y","article-title":"Race, APOE genotypes, and cognitive decline among middle-aged urban adults","volume":"13","author":"Beydoun","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.tins.2023.06.003_bb0775","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-201113","article-title":"Association between APOE alleles and change of neuropsychological tests in the Long Life Family Study","volume":"79","author":"Du","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0780","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3233\/JAD-2009-1160","article-title":"Impact of APOE \u03b54 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians","volume":"18","author":"Carrion-Baralt","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tins.2023.06.003_bb0785","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1037\/0894-4105.20.6.633","article-title":"Prospective memory and apolipoprotein E in healthy aging and early stage Alzheimer\u2019s disease","volume":"20","author":"Duchek","year":"2006","journal-title":"Neuropsychology"},{"key":"10.1016\/j.tins.2023.06.003_bb0790","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003597","article-title":"Association of APOE \u03b54 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: a cross-sectional study","volume":"18","author":"Jin","year":"2021","journal-title":"PLoS Med."},{"key":"10.1016\/j.tins.2023.06.003_bb0795","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12035-013-8400-3","article-title":"MicroRNAs in the brain: it\u2019s regulatory role in neuroinflammation","volume":"47","author":"Thounaojam","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2023.06.003_bb0800","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-200132","article-title":"Interaction between BDNF Val66Met and APOE4 on biomarkers of Alzheimer\u2019s disease and cognitive decline","volume":"78","author":"Stonnington","year":"2020","journal-title":"J. Alzheimers Dis."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166223623001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:23:27Z","timestamp":1759062207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166223623001418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":160,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0166223623001418"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2023.06.003","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More than just risk for Alzheimer\u2019s disease: APOE \u03b54's impact\u00a0on the aging brain","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2023.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}